VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 44 filers reported holding VINCERX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,071 | -20.1% | 24,822 | +2.8% | 0.00% | – |
| Q2 2023 | $31,387 | +25.0% | 24,144 | 0.0% | 0.00% | – |
| Q1 2023 | $25,110 | +8.4% | 24,144 | +6.3% | 0.00% | – |
| Q4 2022 | $23,159 | -54.6% | 22,705 | -37.8% | 0.00% | – |
| Q3 2022 | $51,000 | -26.1% | 36,525 | -28.8% | 0.00% | – |
| Q2 2022 | $69,000 | -47.3% | 51,268 | +57.5% | 0.00% | – |
| Q1 2022 | $131,000 | -58.3% | 32,556 | +5.6% | 0.00% | – |
| Q4 2021 | $314,000 | -44.1% | 30,833 | -11.3% | 0.00% | – |
| Q3 2021 | $562,000 | +34.1% | 34,751 | +7.6% | 0.00% | – |
| Q2 2021 | $419,000 | +87.1% | 32,311 | +177.2% | 0.00% | – |
| Q1 2021 | $224,000 | +409.1% | 11,657 | +450.1% | 0.00% | – |
| Q4 2020 | $44,000 | – | 2,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $6,473,000 | 1.96% |
| Affinity Asset Advisors, LLC | 1,374,098 | $5,496,000 | 0.88% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $4,123,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 720,161 | $2,881,000 | 0.41% |
| Rubric Capital Management LP | 2,107,000 | $8,428,000 | 0.30% |
| Long Focus Capital Management, LLC | 430,200 | $1,721,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 327,236 | $1,309,000 | 0.20% |
| Clearline Capital LP | 412,657 | $1,651,000 | 0.19% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $1,540,000 | 0.16% |
| Sio Capital Management, LLC | 102,049 | $408,000 | 0.14% |